Heparin-induced thrombocytopenia screening: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Heparin-induced thrombocytopenia}} | {{Heparin-induced thrombocytopenia}} | ||
{{CMG}}; | {{CMG}}; | ||
==Overview== | ==Overview== |
Revision as of 19:42, 17 June 2016
Heparin-induced thrombocytopenia |
Differentiating Heparin-induced thrombocytopenia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Heparin-induced thrombocytopenia screening On the Web |
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia screening |
Directions to Hospitals Treating Heparin-induced thrombocytopenia |
Risk calculators and risk factors for Heparin-induced thrombocytopenia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];